Search - tctmd.com

Displaying 81 - 100 of 109

Sort: Relevancy | Date

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

News Conference News HRS 2019

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

May 15, 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

March 22, 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

March 17, 2019

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

News Conference News AHA 2018

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Yael L. Maxwell

November 12, 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

November 02, 2018

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

July 30, 2018

Class I Recall for Medtronic’s HeartWare HVAD System

News Daily News

Class I Recall for Medtronic’s HeartWare HVAD System

Michael O'Riordan

June 04, 2018

News Daily News

HeartMate 3 Problem With Outflow Graft Twisting Called Class I Recall by FDA

May 23, 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

News Conference News ACC 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

March 16, 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

FDA Grants HeartWare LVAD a Destination Therapy Indication

News Daily News

FDA Grants HeartWare LVAD a Destination Therapy Indication

September 28, 2017

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

News Daily News

HeartMate II Left Ventricular Assist System Under Recall Due to Controller Exchange Problems

May 24, 2017

Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial

News Conference News

Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial

April 07, 2017

Echocardiography in the Management of Patients With Left Ventricular Assist Devices

Presentation ECHO 2017

Echocardiography in the Management of Patients With Left Ventricular Assist Devices

Presenter: Michael H. Picard

March 31, 2017

News Daily News

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Michael O'Riordan

October 17, 2016

News Opinion Fellow Talk

Hemodynamics Galore: What I Learned at the C3 Summit

Tiffany Patterson, MBBS

July 27, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.